Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783880 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07783880 · ClinicalTrials.gov record · last posted 2026-08-25

Investigation to Assess the Effects of Drug-COATED Balloons for Treatment of Plaques Erosions Causing Acute Coronary Syndromes

Study acronym: DCB-PE
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-10-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Drug eluting balloon angioplasty might be a better alternative than medical treatment or stenting in subjects with plaque erosion, which is the second most common cause of myocardial infarction. The main objective of this pilot study is to gain clear insights on the effect of percutaneous coronary intervention (PCI) with size matched DCB (SeQuent) as compared to treatment with GP IIbIIIa inhibitor or heparin \& dual antiplatelet therapy in a predominantly Caucasian population at 2 days and at 1 year after the procedure.
Trial Details
NCT Number NCT07783880
Lead Sponsor 3W-Research Collaboration Group
Conditions Myocardial Infarction, Percutaneous Coronary Intervention (PCI), Medical Treatment, Coronary Computed Tomographic Angiography, Computed Tomography, Optical Coherence Tomography (OCT)
Enrollment 62 participants
Start Date 2026-10-01
Primary Completion 2029-10-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-25